Compare Sanofi India with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ALEMBIC PHARMA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ALEMBIC PHARMA SANOFI INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 42.1 16.0 262.9% View Chart
P/BV x 8.6 6.4 134.6% View Chart
Dividend Yield % 1.0 0.6 169.8%  

Financials

 SANOFI INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ALEMBIC PHARMA
Mar-19
SANOFI INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs6,840664 1,030.1%   
Low Rs4,630412 1,122.7%   
Sales per share (Unadj.) Rs1,203.1208.7 576.4%  
Earnings per share (Unadj.) Rs165.331.0 533.1%  
Cash flow per share (Unadj.) Rs209.937.1 565.5%  
Dividends per share (Unadj.) Rs84.005.50 1,527.3%  
Dividend yield (eoy) %1.51.0 143.3%  
Book value per share (Unadj.) Rs963.6144.2 668.2%  
Shares outstanding (eoy) m23.03188.52 12.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.82.6 184.9%   
Avg P/E ratio x34.717.4 199.9%  
P/CF ratio (eoy) x27.314.5 188.4%  
Price / Book Value ratio x6.03.7 159.5%  
Dividend payout %50.817.7 286.5%   
Avg Mkt Cap Rs m132,078101,461 130.2%   
No. of employees `0003.3NA-   
Total wages/salary Rs m4,0687,467 54.5%   
Avg. sales/employee Rs Th8,393.8NM-  
Avg. wages/employee Rs Th1,232.4NM-  
Avg. net profit/employee Rs Th1,153.0NM-  
INCOME DATA
Net Sales Rs m27,70839,347 70.4%  
Other income Rs m89794 956.3%   
Total revenues Rs m28,60539,441 72.5%   
Gross profit Rs m6,2358,736 71.4%  
Depreciation Rs m1,0271,152 89.1%   
Interest Rs m7184 3.8%   
Profit before tax Rs m6,0987,493 81.4%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2921,568 146.2%   
Profit after tax Rs m3,8065,844 65.1%  
Gross profit margin %22.522.2 101.4%  
Effective tax rate %37.620.9 179.7%   
Net profit margin %13.714.9 92.5%  
BALANCE SHEET DATA
Current assets Rs m15,92219,577 81.3%   
Current liabilities Rs m6,23514,896 41.9%   
Net working cap to sales %35.011.9 293.9%  
Current ratio x2.61.3 194.3%  
Inventory Days Days6490 70.9%  
Debtors Days Days2145 46.0%  
Net fixed assets Rs m7,53927,097 27.8%   
Share capital Rs m230377 61.0%   
"Free" reserves Rs m21,96226,811 81.9%   
Net worth Rs m22,19227,188 81.6%   
Long term debt Rs m04,993 0.0%   
Total assets Rs m29,83947,778 62.5%  
Interest coverage x872.141.7 2,091.4%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.90.8 112.8%   
Return on assets %12.812.6 101.3%  
Return on equity %17.221.5 79.8%  
Return on capital %27.523.6 116.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58719,453 39.0%   
Fx outflow Rs m7,1456,065 117.8%   
Net fx Rs m44213,388 3.3%   
CASH FLOW
From Operations Rs m3,7398,120 46.0%  
From Investments Rs m-731-7,556 9.7%  
From Financial Activity Rs m-1,972590 -334.0%  
Net Cashflow Rs m1,0361,153 89.8%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 2.9 496.6%  
FIIs % 14.6 9.1 160.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 13.9 75.5%  
Shareholders   15,184 49,328 30.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   WYETH  IPCA LABS  NATCO PHARMA  NEULAND LABS  PIRAMAL ENTERPRISES  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 26, 2021 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - IPCA LABS COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS